Direct-to-Consumer Drug Ads: Hype or Help?
Irvine News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Direct-to-consumer ads for prescription drugs like Ozempic are under scrutiny, with critics arguing they oversell expensive new pills that offer little advantage over cheaper generics. Novo Nordisk, the maker of Ozempic, spent millions on ads, leading to increased usage and positive results for some patients like Tamar Abrams. However, the FDA has called for limits on these ads, and senators have introduced bills to ban or curb them, as the debate over their effectiveness and ethics continues to grow.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/e1cdc40ae82072c5